All News
Filter News
Found 4,857 articles
-
Pain Therapeutics Licenses Biotechnology To Treat Rare Disorder
3/22/2007
-
Baxter International, Inc. Holds 2007 Investor Conference in Chicago
3/14/2007
-
Baxter International, Inc.'s Board of Directors Expands Share Repurchase Authorization By $2 Billion
3/13/2007
-
Grifols Announces Expansion of US Manufacturing Capacity
3/13/2007
-
Baxter Healthcare Corporation Initiates Multi-Center Phase II Clinical Trial to Manage Fluid Overload in Congestive Heart Failure Patients
3/12/2007
-
Baxter International, Inc. 2007 Investor Conference
3/9/2007
-
Baxter International, Inc. 2007 Investor Conference
3/9/2007
-
Wyeth and Progenics Pharmaceuticals, Inc. to Begin Clinical Testing of a New Formulation of Oral Methylnaltrexone Based on Phase 2 Findings
3/7/2007
-
Sangamo BioSciences, Inc. to Present at the Cowen and Company 27th Annual Health Care Conference
3/7/2007
-
Baxter International, Inc. and its Foundation Contribute More Than $35 Million in 2006 to Address Local and Global Critical Needs
3/6/2007
-
Baxter International, Inc. Completes Sale of Transfusion Therapies Business for $540 Million
3/1/2007
-
Wyeth European Committee Issued Positive Opinions to Extend Indication for PREVENAR to Include Pneumonia and Otitis Media
3/1/2007
-
Baxter Healthcare Corporation Receives 510(k) Clearance From FDA for COLLEAGUE Infusion Pumps
2/27/2007
-
CSL Behring Release: Study Finds C1-Inhibitor Concentrate is Safe and Effective in Treating Skin Swelling in Patients With Hereditary Angioedema
2/27/2007
-
Bayer HealthCare AG Awards Grant to National Hemophilia Foundation's Youth Leadership Institute
2/27/2007
-
CSL Behring's Helixate(R) FS And Mix2Vial(TM) Now Packaged Together To Optimize Patient Safety And Convenience
2/20/2007
-
The American Thrombosis And Hemostasis Network Receives Five-Year Grant From Novo Nordisk A/S
2/16/2007
-
Halozyme Therapeutics, Inc. And Baxter International, Inc. Present Promising Results For The Use Of HYLENEX From The Infuse-Morphine Study
2/15/2007
-
Halozyme Therapeutics, Inc. And Baxter International, Inc. Expand Biologic Partnership; Total Collaboration Valued Up To $65 Million
2/14/2007
-
Baxter International, Inc. Names Robert Hombach Treasurer
2/14/2007